TY - JOUR
T1 - The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion
AU - Han, Ping
AU - Werber, John
AU - Surana, Manju
AU - Fleischer, Norman
AU - Michaeli, Tamar
PY - 1999/8/6
Y1 - 1999/8/6
N2 - To understand the role cAMP phosphodiesterases (PDEs) play in the regulation of insulin secretion, we analyzed cyclic nucleotide PDEs of a pancreatic β-cell line and used family and isozyme-specific PDE inhibitors to identify the PDEs that counteract glucose-stimulated insulin secretion. We demonstrate the presence of soluble PDE1C, PDE4A and 4D, a cGMP-specific PDE, and of particulate PDE3, activities in βTC3 insulinoma cells. Selective inhibition of PDE1C, but not of PDE4, augmented glucose-stimulated insulin secretion in a dose-dependent fashion thus demonstrating that PDE1C is the major PDE counteracting glucose-dependent insulin secretion from βTC3 cells. In pancreatic islets, inhibition of both PDE1C and PDE3 augmented glucose- dependent insulin secretion. The PDE1C of βTC3 cells is a novel isozyme possessing a K(m) of 0.47 μM for cAMP and 0.25 μM for cGMP. The PDE1C isozyme of βTC3 cells is sensitive to 8-methoxymethyl isobutylmethylxanthine and zaprinast (IC50 = 7.5 and 4.5 μM, respectively) and resistant to vinpocetine (IC50 > 100 μM). Increased responsiveness of PDE1C activity to calcium/calmodulin is evident upon exposure of cells to glucose. Enhanced cAMP degradation by PDE1C, due to increases in its responsiveness to calcium/calmodulin and in intracellular calcium, constitutes a glucose- dependent feedback mechanism for the control of insulin secretion.
AB - To understand the role cAMP phosphodiesterases (PDEs) play in the regulation of insulin secretion, we analyzed cyclic nucleotide PDEs of a pancreatic β-cell line and used family and isozyme-specific PDE inhibitors to identify the PDEs that counteract glucose-stimulated insulin secretion. We demonstrate the presence of soluble PDE1C, PDE4A and 4D, a cGMP-specific PDE, and of particulate PDE3, activities in βTC3 insulinoma cells. Selective inhibition of PDE1C, but not of PDE4, augmented glucose-stimulated insulin secretion in a dose-dependent fashion thus demonstrating that PDE1C is the major PDE counteracting glucose-dependent insulin secretion from βTC3 cells. In pancreatic islets, inhibition of both PDE1C and PDE3 augmented glucose- dependent insulin secretion. The PDE1C of βTC3 cells is a novel isozyme possessing a K(m) of 0.47 μM for cAMP and 0.25 μM for cGMP. The PDE1C isozyme of βTC3 cells is sensitive to 8-methoxymethyl isobutylmethylxanthine and zaprinast (IC50 = 7.5 and 4.5 μM, respectively) and resistant to vinpocetine (IC50 > 100 μM). Increased responsiveness of PDE1C activity to calcium/calmodulin is evident upon exposure of cells to glucose. Enhanced cAMP degradation by PDE1C, due to increases in its responsiveness to calcium/calmodulin and in intracellular calcium, constitutes a glucose- dependent feedback mechanism for the control of insulin secretion.
UR - http://www.scopus.com/inward/record.url?scp=0033529693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033529693&partnerID=8YFLogxK
U2 - 10.1074/jbc.274.32.22337
DO - 10.1074/jbc.274.32.22337
M3 - Article
C2 - 10428803
AN - SCOPUS:0033529693
SN - 0021-9258
VL - 274
SP - 22337
EP - 22344
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -